title: [Effects of non-bioartificial liver support system on Gc-globulin in patients with liver failure].
abstract: OBJECTIVE
  To investigate the effects of artificial liver support system(plasma exchange combined with continuous veno - venous hemodiafiltration, PE + CVVHDF) on Gc globulin in patients with liver failure.
  
  
  METHODS
  81 patients with liver failure were divided into 4 groups according to the treatment protocols and indicators such as liver function and clinical symptoms. Totally 29 effective cases and 14 ineffective cases in the ALSS group versus 15 effective cases and 23 ineffective cases in the medical group were included. Finally the changes of Gc globulin were observed in four subgroups before and after treatment. The correlation between Gc globulin and IL-10, IL-4, IL-18, TNFa, endotoxin, NO, sVCAM-1and sICAM-1were analyzed by Pearson correlation analysis.
  
  
  RESULTS
  The effectiveness rate was 67.44% in ALSS group and 34.21% in the medical treatment (P less than 0.01). Gc globulin, one of liver cell protection proteins was notably increased following the artificial liver treatment as compared with the increase in the medical treatment (P less than 0.01). The time-response curve of Gc globulin level had a significant upward trend in the effective group as compared to no significant rise in the ineffective group. Moreover, the Gc globulin was negatively correlated with IL-4, IL-18, TNFa, SVCAM-1, SICAM-1 and NO. In contrast, no correlation existed between Gc globulin and IL-10. The treatment with artificial liver can improve the outcome of the patients with liver failure. The level of Gc globulin was correlated with the curative effect and thus may be used as a potential indicator for curative effect forcast in the patients with liver failure.
authors.affiliation: Department of Nephrology, Shanghai First People's Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
authors.forename: Yong-Ling
authors.initials: YL
authors.lastname: Kuang
authors.forename: Wei-Jie
authors.initials: WJ
authors.lastname: Yuan
authors.forename: Zheng
authors.initials: Z
authors.lastname: Zhang
authors.forename: Tong-Hai
authors.initials: TH
authors.lastname: Xing
authors.forename: Qing
authors.initials: Q
authors.lastname: Yu
authors.forename: Jun
authors.initials: J
authors.lastname: Liu
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
authors.forename: Zhi-Hui
authors.initials: ZH
authors.lastname: Liu
authors.forename: Zhi-Hai
authors.initials: ZH
authors.lastname: Peng
mesh_terms: D000368:Aged; D015815:Cell Adhesion Molecules / Q000097:blood; D016207:Cytokines / Q000097:blood; D005260:Female; D006801:Humans; D017093:Liver Failure / Q000097:blood* / Q000601:surgery / Q000628:therapy*; D019164:Liver, Artificial; D008297:Male; D009569:Nitric Oxide / Q000097:blood; D016896:Treatment Outcome; D014809:Vitamin D-Binding Protein / Q000097:blood* / Q000378:metabolism*
chemical_list: D015815:Cell Adhesion Molecules; D016207:Cytokines; D014809:Vitamin D-Binding Protein; D009569:Nitric Oxide